Study Protocol: Efficacy and Safety of Radioembolization (REM) as an Early Modality (EM) Therapy for Metastatic Breast Cancer (BR) to the Liver with Y90 (REMEMBR Y90).

Richard WuKeerthi GogineniJane MeiselStephen SzaboMeenakshi ThirunavuSarah FriendZachary BercuIla SethiNeela NatarajanJeffrey SwitchenkoJason LevyEddie AbdallaLaura WeaklandKevin KalinskyNima Kokabi

Published in: Cardiovascular and interventional radiology (2022)

NCT05315687 on clinicaltrials.gov.

Keyphrases

metastatic breast cancer
study protocol
randomized controlled trial
clinical trial
liver metastases
open label
double blind
placebo controlled